Amplity Health

Amplity Health specializes in biopharmaceutical services, facilitating drug approval processes and enhancing medical engagement through innovative solutions tailored for the healthcare sector. Amplity Health, founded in 1980, operates in the biopharmaceutical services sector, focusing on improving and accelerating services related to healthcare. The company was acquired by Altamont Capital Partners from Publicis Groupe SA in January 2019. The current CEOs are Alexandra Plato and Michael Griffith.

Amplity has headquarters in the US. Amplity provides a suite of biopharma services designed to expedite drug approval and enhance medical engagement. Their core offerings include Amplity Medical, which focuses on outsourcing global clinical and medical engagement to facilitate accelerated drug approval; Amplity Sales, which delivers flexible and scalable sales teams for rapid product launches and lifecycle management; and Amplity Intel, featuring AnswerY™, an AI-driven, HIPAA-compliant platform that supports prescriber-patient conversations to optimize next-best actions. Additionally, Amplity Comms offers premium content and access to critical oncology care networks, while Amplity Learn emphasizes continuous professional growth for teams and individuals through training led by industry experts.

The company serves a diverse clientele, including pharmaceutical companies and healthcare practitioners, with a geographical focus that spans North America and Europe, particularly in oncology, rare diseases, and specialty medicine. Amplity generates revenue through a structured model focused on B2B engagements with pharmaceutical and biopharma companies. The company's services are typically contracted through partnerships and subscription agreements, where clients pay for customized medical engagement strategies and sales support. For example, engagements with Amplity Medical may involve a long-term contract where clients utilize Amplity’s services for ongoing clinical trials and medical communications, while Amplity Sales may operate under a performance-based fee structure, incentivizing success in product launches.

Specific pricing plans are tailored to the services provided; however, they encompass various levels of engagement depending on the scale and scope of the project. The combination of these services aims to align closely with client objectives, fostering a collaborative environment that prioritizes effective patient outcomes. In October 2018, Altamont Capital Partners acquired Amplity Health, a move aimed at reinforcing the company's focus on enhancing healthcare-related services and growth plans for its clients. The acquisition is expected to support the development of new products and services, particularly in the oncology and specialty medicine sectors.

As part of its expansion strategy, Amplity is targeting increased engagement in European markets while leveraging its existing capabilities in North America. Recent funding will be utilized to enhance its service offerings and pursue strategic partnerships that align with the company's growth objectives.